CD-MEDICS Project to Speed Up Diagnosis of Coeliac Disease

Designing a new tool to aid in the diagnosis and management of coeliac disease is the aim of the EU-funded CD-MEDICS (Coeliac disease management monitoring diagnosis using biosensors and integrated chip systems) project, which has just got underway.

Coeliac disease is an auto-immune condition caused by intolerance to gluten, a protein found in wheat, barley and rye. When people with the disease eat foods containing these products, the gluten damages the gut lining and so prevents food from being digested and absorbed normally.

Symptoms of coeliac disease include diarrhoea, tiredness, anaemia, mouth ulcers, skin problems, depression, joint pain and nerve problems. The only treatment is strict adherence to a gluten free diet.

It is estimated that 1 in 100 Europeans suffer from coeliac disease. However, a recent survey revealed that just 12.5% of those with the disease have been diagnosed correctly, and the average time from the onset of symptoms to diagnosis is over a decade.

During that time, patients have a reduced quality of life and are often misdiagnosed with other conditions that may be treated unnecessarily with costly drugs. If coeliac disease is left untreated, sufferers are at risk of developing other diseases and conditions, such as osteoporosis, infertility, certain gut cancers and other autoimmune diseases. Prompt diagnosis is therefore essential, and this is where the CD-MEDICS project comes in.

Over the next four years, the project will work to develop an easy-to-use test for coeliac disease which can be used in primary care settings to diagnose the condition and monitor the compliance of patients with a gluten free diet.

At the heart of the project is so-called 'lab-on-a-chip' technology. A user simply places a drop of blood onto a device the size of a credit card which is then inserted into a machine that runs the tests automatically. The card consists of a microstructured network to control the flow of chemicals and a specially adapted surface to capture the biological components being looked for, and a sensor system designed to enable fast detection.

In this case, the device will screen for two things: the genes which make some people more susceptible to developing coeliac disease, and the auto-antibodies which can reveal whether someone has the disease or, in the case of existing patients, whether or not they are complying with their gluten free diet.

The new diagnostic tool will also contain embedded communication technologies to allow direct storage of test results on the patient's electronic medical record. This will help doctors and other healthcare workers interpret the results and manage each patient individually. Eventually the partners hope to integrate the technology into a device that can be used in the home, so that doctors can monitor their patients' progress remotely.

The technologies developed by the project could also find application in the detection of a number of other serious health conditions, such as diabetes and rheumatoid arthritis.

Funded to the tune of €9.5 million under the FP7 ICT Challenge 5: Sustainable and Personalised Healthcare theme, the project brings together 21 universities, hospitals and technology centres in 10 European countries.

For further information, please visit:
http://www.cdmedics.eu

Related article:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...